Search results
Results from the WOW.Com Content Network
Tinidazole, sold under the brand name Tindamax among others, is a medication used against protozoan infections. It is widely known throughout Europe and the developing world as a treatment for a variety of anaerobic amoebic and bacterial infections. It was developed in 1972 and is a prominent member of the nitroimidazole antibiotic class. [2]
The principal for obstetric management of COVID-19 include rapid detection, isolation, and testing, profound preventive measures, regular monitoring of fetus as well as of uterine contractions, peculiar case-to-case delivery planning based on severity of symptoms, and appropriate post-natal measures for preventing infection.
The 5-nitroimidazole drugs (metronidazole and tinidazole) are the mainstay of treatment for infection with Trichomonas vaginalis. Treatment for both the infected patient and the patient's sexual partner is recommended, even if asymptomatic. Therapy other than 5-nitroimidazole drugs is also an option, but cure rates are much lower. [25]
If you recently tested positive for COVID-19, you may be eligible for antiviral treatments to help reduce your infection. Earlier this year, when the omicron variant was steering the pandemic, ...
Metronidazole 400 mg three times a day for 10 days; Tinidazole 2g once a day for 6 days is an alternative to metronidazole; Diloxanide furoate 500 mg three times a day for 10 days (or one of the other lumenal amebicides above) must always be given afterwards
Acne Spot Dots. While some acne-fighting products can be a bit pricey, these are super budget-friendly. For only nine dollars, you can get 60 vegan patches designed to reduce inflammation and the ...
The mRNA COVID-19 vaccines do this by causing the body to create a piece of a protein similar to one found in the coronavirus. (The protein that the body creates in response to the mRNA vaccine is ...
Bebtelovimab is a neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19.